TODAY AT IGTP

News

28/01/2026 - Research

Study identifies PARG as a new target to enhance chemotherapy in colorectal cancer

A study led by researchers from the Resistance, Chemotherapy and Predictive Biomarkers group at the IGTP, published in Clinical and Translational Medicine, provides new evidence on how to improve the efficacy of one of the most widely used chemotherapy combinations in clinical practice for the treatment of colorectal cancer: 5-fluorouracil and irinotecan (FUIRI).

Events